Abstract: The present disclosure provides compounds of the formula (III) and their pharmaceutically acceptable salts, and compounds of the formula (IV) and their pharmaceutically acceptable salts, and pharmaceutical compositions comprising these compounds, as well as intermediates for preparing the compounds.
| # | Name | Date |
|---|---|---|
| 1 | 202417053031-STATEMENT OF UNDERTAKING (FORM 3) [11-07-2024(online)].pdf | 2024-07-11 |
| 2 | 202417053031-PRIORITY DOCUMENTS [11-07-2024(online)].pdf | 2024-07-11 |
| 3 | 202417053031-POWER OF AUTHORITY [11-07-2024(online)].pdf | 2024-07-11 |
| 4 | 202417053031-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [11-07-2024(online)].pdf | 2024-07-11 |
| 5 | 202417053031-MARKED COPIES OF AMENDEMENTS [11-07-2024(online)].pdf | 2024-07-11 |
| 6 | 202417053031-FORM 18 [11-07-2024(online)].pdf | 2024-07-11 |
| 7 | 202417053031-FORM 13 [11-07-2024(online)].pdf | 2024-07-11 |
| 8 | 202417053031-FORM 1 [11-07-2024(online)].pdf | 2024-07-11 |
| 9 | 202417053031-DECLARATION OF INVENTORSHIP (FORM 5) [11-07-2024(online)].pdf | 2024-07-11 |
| 10 | 202417053031-COMPLETE SPECIFICATION [11-07-2024(online)].pdf | 2024-07-11 |
| 11 | 202417053031-AMMENDED DOCUMENTS [11-07-2024(online)].pdf | 2024-07-11 |
| 12 | 202417053031-Proof of Right [17-12-2024(online)].pdf | 2024-12-17 |
| 13 | 202417053031-FORM 3 [17-12-2024(online)].pdf | 2024-12-17 |